IGF-1 LR3 – A Powerful Growth Factor Peptide

All products discussed on this page are sold strictly for laboratory and in-vitro research use only (RUO). They are not drugs, dietary supplements, or cosmetics, are not intended for human or animal consumption, and are not intended to diagnose, treat, cure, or prevent any disease. This content is for educational and research-literature reference purposes only and does not constitute dosing, medical, or usage advice.

What is IGF-1 LR3?

IGF-1 LR3, also known as Long Arginine 3-IGF-1, is a modified form of the insulin-like growth factor-1 (IGF-1) protein. This synthetic analog of natural IGF-1 features an arginine substitution at the third amino acid position and an additional thirteen amino acids at its N-terminus. These structural modifications result in a significantly longer half-life and a lower affinity for IGF binding proteins (IGFBPs), making IGF-1 LR3 a more potent and longer-lasting form of IGF-1. The extended half-life allows for prolonged activity in the body, enhancing its effectiveness in various research and experimental applications.

Structure and Properties of Insulin Like Growth Factor IGF-1 LR3

IGF-1 LR3 is a synthetic peptide consisting of 83 amino acids, featuring an additional 13 amino acid extension at the N-terminus compared to native insulin-like growth factor 1 (IGF-1). This modification results in several key advantages, making IGF-1 LR3 a focus of scientific interest:

Comparison to Natural IGF-1

While IGF-1 LR3 shares the ability to stimulate cellular proliferation and growth with natural IGF-1, its modified structure provides distinct advantages. The longer half-life of IGF-1 LR3 means it remains active

Key Advantages:

• Increased Half-Life: Research suggests that IGF-1 LR3 possesses a significantly extended half-life of 20-30 hours, compared to just 10-20 minutes for native IGF-1. This prolonged duration may enhance its effectiveness in research applications.

Mechanism of Action:

IGF-1 LR3 primarily functions by binding to the IGF-1 receptor (IGF-1R) on cell surfaces, initiating a cascade of intracellular signaling pathways.

• Protein Synthesis: Facilitates the production of proteins essential for cellular functions and growth.

The unique properties of IGF-1 LR3 have made it a valuable tool in various research areas:

Considerations and Limitations of IGF Binding Proteins

Despite the numerous advantages IGF-1 LR3 presents in research environments, several factors should be taken into account:

– Researchers must ensure that the concentration of IGF-1 LR3 is optimized to prevent any adverse effects that could arise from excessive cellular proliferation or unintended interactions with other growth factors. Monitoring fetal growth is particularly important in studies involving IGF-1 LR3 to understand its impact on development.

– The long-term impact of IGF-1 LR3 on cellular systems is not yet fully understood and warrants further study. Ongoing research is crucial to elucidate the potential implications of prolonged exposure to IGF-1 LR3, particularly concerning its effects on cellular aging, differentiation, and the risk of oncogenesis. Researchers should also be aware of the potential risks of intrauterine growth restriction (IUGR) in studies involving IGF-1 LR3, as abnormal IGF-1 levels can affect fetal growth outcomes.

– In many regions, the utilization of IGF-1 LR3 is strictly regulated and confined to research purposes only. Regulatory bodies closely monitor its distribution and application to ensure ethical standards are maintained, and its use is limited to controlled environments. This regulatory oversight is essential to prevent misuse and to safeguard against the unauthorized application of IGF-1 LR3 in non-research contexts.

Furthermore, the ethical implications of using IGF-1 LR3 in experimental research must be addressed. Studies involving animal models or human cell lines should adhere to ethical guidelines to ensure the welfare of subjects and the integrity of scientific inquiry.

Buy Wholesale IGF-1 LR3 Peptide

We offer IGF-1 LR3, a powerful synthetic peptide with significant potential in scientific research and biotechnology applications. As research continues, we may uncover new applications and insights into the role of IGF-1 signaling in biological processes, including its impact on fetal nutrient availability and placental blood flow.

The unique properties of IGF-1 LR3 have led to its investigation across numerous scientific domains. Studies on late gestation fetal sheep have shown that IGF-1 LR3 infusion can significantly impact growth and development, particularly in nutrient uptake and organ-specific growth.

In the field of oncology, researchers are examining the implications of IGF-1 LR3 in cancer research, particularly its effects on cell proliferation and tumor growth. Understanding the signaling pathways influenced by IGF-1 LR3 could provide valuable insights into new cancer treatment strategies and the development of targeted therapies.

The significance of umbilical cord blood concentrations of IGF-1 and IGFBPs is also being studied, as these levels are linked to fetal growth and pregnancy complications.

However, ethical considerations and regulatory restrictions play a crucial role in determining its application in this area.

Overall, the exploration of IGF-1 LR3’s diverse applications continues to expand, promising advancements in various scientific and medical fields.

Conclusion

However, the necessity for careful monitoring and ethical consideration in its use cannot be overstated. As research progresses, IGF-1 LR3 may unlock new opportunities

References

1. Clemmons, D. R. (2009). Trends in Endocrinology & Metabolism, 20(8), 349-356.

2. Butler, A. A., & Le Roith, D. (2001). Annual Review of Physiology, 63(1), 141-164.

3. Jones, J. I., & Clemmons, D. R. (1995). Endocrine Reviews, 16(1), 3-34.

4. Bach, L. A. (2018). Insulin-like growth factor binding proteins. Vitamins and Hormones, 99, 165-206.

5. Laron, Z. (2001). Insulin-like growth factor 1 (IGF-1): A growth hormone. Molecular Pathology, 54(5), 311-316.

6. Yakar, S., & Adamo, M. L. (2012). Endocrinology and Metabolism Clinics, 41(2), 231-247.

7. De Meyts, P. (2004). Insulin and its receptor: Structure, function and evolution. BioEssays, 26(12), 1351-1362.

8. Rosen, C. J., & Pollak, M. (1999). Circulating IGF-I: New perspectives for a new century. Trends in Endocrinology & Metabolism, 10(4), 136-141.

9. Juul, A. (2003). Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Hormone & IGF Research, 13(4), 113-170.

10. Le Roith, D., Bondy, C., Yakar, S., Liu, J. L., & Butler, A. (2001). The somatomedin hypothesis: 2001. Endocrine Reviews, 22(1), 53-74.

These references provide a comprehensive overview of the current understanding of IGF-1 LR3, its mechanisms, and its potential applications in research and therapy.